Fundraising Fox

Corindus Vascular Robotics

Waltham, US · Founded 2011 · Delaware corporation · 2 known investors

Find your way into Corindus Vascular Robotics

75 people in our graph share verified history with the Corindus Vascular Robotics team — schools, employers, funds. One of them is your warm intro.

Evan Pritchardunlockedknows Mark Toland · together at Corindus Vascular Robotics (overlapped)
×2knows the team · via Cardiologs
×2knows the team · via Moon Surgical
knows the team · via Medical Micro Instruments
×5knows the team · via University of Louisville
knows the team · via Wallace Computer Services
Healthtech

Founders & leadership

SJ
Stephen J. LemasterExecutive
MJMark J. Toland
Mark J. TolandinPresident and CEO2016–2020Mark Toland is CEO of MMI SpA, having previously served as President and CEO of Corindus Vascular Robotics, which was acquired by Siemens Healthineers. He previously held the role of Senior Vice President at Boston Scientific, where he oversaw cardiovascular commercial operations, and holds a Bachelor of Science in Business Administration from the University of Louisville.
DW
David W. LongExecutive
DM
David M HandlerExecutive

Board

JC
Jeffrey C. LightcapBoard director
LA
Louis A. CannonBoard directorGeneral Partner at BioStar Ventures
GW
Gerard WinkelsBoard director
HBHillel Bachrach
Hillel BachrachinBoard directorManaging Partner at 20/20 HealthCare Partners LLC
DW
David WhiteBoard director
CD
Campbell D. RogersBoard director
JG
Jeffrey G. GoldBoard director
MM
Michael MashaalBoard director

Investors · 2

20/20 HealthCare Partners LLCAuburndalevia Hillel Bachrach · led
BioStar VenturesreportedPetoskey

Reported raises · per SEC filings

Form D private placements

$117.1M disclosed across 7 rounds · 2014–2019

▶$4.8MraisedMar 2019 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas TeanyExecutive Officer
  • Nathan R. HarringtonDirector
  • James R. TobinDirector
  • Campbell D. RogersDirector
  • David W. LongExecutive Officer
  • Mark J. TolandExecutive Officer, Director
  • Douglas L. BraunsteinDirector
  • Jeffrey G. GoldDirector
  • Louis A. CannonDirector
  • Jeffrey C. LightcapDirector
Offering amount
$4.8M
Amount sold
$4.8M
First sale
Mar 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$413.9KraisedMar 2019 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas TeanyExecutive Officer
  • Campbell D. RogersDirector
  • Nathan R. HarringtonDirector
  • Douglas L. BraunsteinDirector
  • Jeffrey C. LightcapDirector
  • Jeffrey G. GoldDirector
  • Mark J. TolandExecutive Officer, Director
  • David W. LongExecutive Officer
  • James R. TobinDirector
  • Louis A. CannonDirector
Offering amount
$413.9K
Amount sold
$413.9K
First sale
Mar 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedMar 2019 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey C. LightcapDirector
  • Douglas TeanyExecutive Officer
  • David W. LongExecutive Officer
  • Campbell D. RogersDirector
  • James R. TobinDirector
  • Nathan R. HarringtonDirector
  • Douglas L. BraunsteinDirector
  • Mark J. TolandExecutive Officer, Director
  • Louis A. CannonDirector
  • Jeffrey G. GoldDirector
Offering amount
$15M
Amount sold
$15M
First sale
Feb 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25MraisedMar 2018 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey G. GoldDirector
  • Douglas L. BraunsteinDirector
  • Campbell D. RogersDirector
  • Nthan R. HarringtonDirector
  • Jeffrey C. LightcapDirector
  • Mark J. TolandExecutive Officer, Director
  • David W. LongExecutive Officer
  • Louis A. CannonDirector
  • James R. TobinDirector
Offering amount
$25M
Amount sold
$25M
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$180KraisedMar 2018 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas L. BraunsteinDirector
  • James R. TobinDirector
  • Jeffrey C. LightcapDirector
  • Jeffrey G. GoldDirector
  • Nathan R. HarringtonDirector
  • Campbell D. RogersDirector
  • Louis A. CannonDirector
  • David W. LongExecutive Officer
  • Mark J. TolandExecutive Officer, Director
Offering amount
$180K
Amount sold
$180K
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$45MraisedMar 2017 · 16 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey C. LightcapDirector
  • Campbell D. RogersDirector
  • Stephen J. LemasterExecutive Officer
  • Louis A. CannonDirector
  • Mark J. TolandExecutive Officer, Director
  • Jeffrey G. GoldDirector
  • David W. LongExecutive Officer
  • Gerard WinkelsDirector
Offering amount
$45M
Amount sold
$45M
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$26.7MraisedSep 2014 · 15 investors · Other Health Care
Rule 506(c)
Officers, directors & promoters on the filing
  • Jeffrey C LightcapDirector
  • David W LongExecutive Officer
  • Michael MashaalDirector
  • Jeffrey GoldDirector
  • David M HandlerExecutive Officer, Director
  • Gerard WinkelsDirector
  • Hillel BachrachDirector
  • David WhiteDirector
Offering amount
$26.7M
Amount sold
$26.7M
Minimum investment
$100K
Sales commissions
$1M
Placement agents
Cowen and Company, LLC, Stifel, Nicolaus & Company, Incorporated
First sale
Sep 2014
Incorporated
Corporation, Nevada, 2011
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Corindus raises $25M to commercialize CorPath GRX surgical robot - Mass Tech Leadership Councilmtlc.co · Apr 2018Corindus Vascular Robotics raises $42Mrobohub.org · Jun 2015Corindus Vascular Robotics, Inc. Closes Private Placement for $26.6 Million | tctmd.comtctmd.com · Sep 2014Buy Corindus Vascular Robotics Stock – CVRS Stock Quote Today & Investment Insights - Public.compublic.com

Frequently asked questions

Who are Corindus Vascular Robotics's investors?
Corindus Vascular Robotics's investors include 20/20 HealthCare Partners LLC, BioStar Ventures.
How much funding has Corindus Vascular Robotics raised?
Corindus Vascular Robotics has disclosed $117.1M raised across 7 rounds.
Where is Corindus Vascular Robotics headquartered?
Corindus Vascular Robotics is headquartered in Waltham, US.